Wixela vs Flovent
What to choose Wixela or Flovent
Wixela is inhaler of type Control while Flovent is of Control type. Wixela and Flovent are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Flovent is manufactured by GSK. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substance of Flovent is Fluticasone. The available dosages for Flovent are 44 mcg, 110 mcg, 220 mcg.
The current cost for Wixela is roughly $240 while current cost for Flovent is roughly $198, said Ezequiel King, an Assistant Professor at the Miami University of Ohio and a Physician at a clinic that uses Wixela and Flovent.
Wixela and Flovent Comparison
| Wixela | Flovent | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | Viatris | GSK |
| Substance: | Fluticasone + Salmeterol | Fluticasone |
| Dosage: | 250/50 | 44 mcg, 110 mcg, 220 mcg |
| Avg Price: | $240 | $198 |